Finance

Lists
000963:SHE
Huadong Medicine Co., Ltd.
CN¥ २६.२५
-०.१९%
(-०.०५०) 1D
अक्टोबर १६, १५:०४:२४ GMT+८  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000963...
Open
CN¥ २६.४३
High
CN¥ २६.९०
Low
CN¥ २५.९८
Mkt. cap
४६.०४ अरब
Avg. vol.
१.३३ करोड
Volume
१.५९ करोड
Dividend
३.५४%
Quarterly dividend
CN¥ ०.२३
Ex-dividend date
२०२६ सेप्टेम्बर १८
P/E ratio
१३.२७
52-wk high
CN¥ ४३.७८
52-wk low
CN¥ २५.६३
EPS
CN¥ १.९८
Shares outstanding
१.७५ अरब
No. of employees
१९ हजार
Open
CN¥ २६.४३
High
CN¥ २६.९०
Low
CN¥ २५.९८
Mkt. cap
४६.०४ अरब
Avg. vol.
१.३३ करोड
Volume
१.५९ करोड
Dividend
३.५४%
Quarterly dividend
CN¥ ०.२३
Ex-dividend date
२०२६ सेप्टेम्बर १८
P/E ratio
१३.२७
52-wk high
CN¥ ४३.७८
52-wk low
CN¥ २५.६३
EPS
CN¥ १.९८
Shares outstanding
१.७५ अरब
No. of employees
१९ हजार
News stories
From web sources and news partners
MarketBeat
MarketBeat
·
५९ मिनेट पहिले
Fox Corporation (NASDAQ:FOX) Stock Has Average Price Target of $76.56
Simply Wall Street
Simply Wall Street
·
१ घण्टा पहिले
What Pacira BioSciences Doubters Got Wrong
Profile
HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since December 1999. It has a listed share capital of 380,000,000 RMB and a market capitalization of 5.1981 billion RMB as of June 2026. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China. In June 2025, the company received approval to commence clinical trials for Roflumilast Foam, targeting dermatological conditions. Wikipedia
About Huadong Medicine Co., Ltd.
CEO-
Employees१९.१ हजार
Founded१९९३ मार्च ३१
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१०.९९ अरब
१०.९५ अरब
११.१८ अरब
१०.८८ अरब
Cost of goods sold
७.३९ अरब
७.७९ अरब
७.३९ अरब
७.४५ अरब
Cost of revenue
७.३९ अरब
७.७९ अरब
७.३९ अरब
७.४५ अरब
Research and development expenses
५०.७९ करोड
२४.५६ करोड
३५.०४ करोड
३९.६७ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.९३ अरब
१.९९ अरब
२.१९ अरब
१.९२ अरब
Operating expense
२.३३ अरब
२.५१ अरब
२.६० अरब
२.४१ अरब
Total operating expenses
९.७२ अरब
१०.३१ अरब
९.९९ अरब
९.८६ अरब
Operating income
१.२७ अरब
६४.२९ करोड
१.१९ अरब
१.०३ अरब
Other non operating income
-७.२१ करोड
५.३६ करोड
-४०.९३ लाख
-१.०६ करोड
EBT including unusual items
१.०७ अरब
७५.३८ करोड
१.१९ अरब
१.०२ अरब
EBT excluding unusual items
१.१९ अरब
७२.३४ करोड
१.१९ अरब
१.०१ अरब
Income tax expense
१३.०९ करोड
८.४९ करोड
१९.५० करोड
१७.६१ करोड
Effective tax rate
१२.२४%
११.२६%
१६.३६%
१७.२८%
Other operating expenses
-१०.५७ करोड
२२.४० करोड
५.८९ करोड
६.३४ करोड
Net income
९३.३१ करोड
६६.६४ करोड
१.०० अरब
८५.८६ करोड
Net profit margin
८.४९%
६.०९%
८.९६%
७.८९%
Earnings per share
०.५४
-
-
-
Interest and investment income
२.६७ करोड
१.३० करोड
२.०२ करोड
१.८४ करोड
Interest expense
-३.३७ करोड
-
-१.९२ करोड
-१.२० करोड
Net interest expenses
-६९.८८ लाख
१.३० करोड
९.७९ लाख
६३.३३ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
१.४६ अरब
८७.३६ करोड
१.४३ अरब
१.२९ अरब
Gain or loss from assets sale
-६२.०१ लाख
-२२.६३ लाख
-
-१४.२४ लाख
AI content may include mistakes. Learn more
Google एपहरू